OpenLegislation

Division 5 Specific additional proceduresF1

United Kingdom Repealed

Original text. Later amendments are not shown.

  1. 5.1Assessment procedure for certain class III and class IIb devices
  2. 5.2Procedure in the case of devices incorporating a medicinal substance
  3. 5.3Procedure in the case of devices manufactured utilising, or incorporating, tissues or cells of human or animal origin, or their derivatives, that are non-viable or rendered non-viable
  4. 5.4Procedure in the case of devices that are composed of substances or of combinations of substances that are absorbed by or locally dispersed in the human body

Annotations

Textual amendments

F1

Regulation revoked (31.12.2020) by The Medical Devices Regulations 2002 (S.I. 2002/618), reg. 4O (with savings and transitional provisions for N.I. in reg. 3ZA) (as amended by S.I. 2019/791, regs. 1(1), 3(7) and by S.I. 2020/1478, regs. 1(3), Sch. 2 para. 2; and as amended (27.7.2021) by The Medical Devices (Northern Ireland Protocol) Regulations 2021 (S.I. 2021/905), regs. 1(2), 4, 32); 2020 c. 1, Sch. 5 para. 1(1))